These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 28131640)

  • 1. The burden of healthcare-associated Clostridium difficile infection in a non-metropolitan setting.
    Bond SE; Boutlis CS; Yeo WW; Pratt WAB; Orr ME; Miyakis S
    J Hosp Infect; 2017 Apr; 95(4):387-393. PubMed ID: 28131640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of multisite antimicrobial stewardship programme implementation with a shared clinical decision support system.
    Bond SE; Chubaty AJ; Adhikari S; Miyakis S; Boutlis CS; Yeo WW; Batterham MJ; Dickson C; McMullan BJ; Mostaghim M; Li-Yan Hui S; Clezy KR; Konecny P
    J Antimicrob Chemother; 2017 Jul; 72(7):2110-2118. PubMed ID: 28333302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of fixed and variable hospital costs due to Clostridium difficile infection: institutional incentives and directions for future research.
    Ryan P; Skally M; Duffy F; Farrelly M; Gaughan L; Flood P; McFadden E; Fitzpatrick F
    J Hosp Infect; 2017 Apr; 95(4):415-420. PubMed ID: 28320542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of antibiotics and case exposure on hospital-acquired Clostridium difficile infection independent of illness severity.
    Forster AJ; Daneman N; van Walraven C
    J Hosp Infect; 2017 Apr; 95(4):400-409. PubMed ID: 27825674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospitalization stay and costs attributable to Clostridium difficile infection: a critical review.
    Gabriel L; Beriot-Mathiot A
    J Hosp Infect; 2014 Sep; 88(1):12-21. PubMed ID: 24996516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of an antimicrobial stewardship intervention on outcomes for patients with Clostridium difficile infection.
    Welch HK; Nagel JL; Patel TS; Gandhi TN; Chen B; De Leon J; Chenoweth CE; Washer LL; Rao K; Eschenauer GA
    Am J Infect Control; 2016 Dec; 44(12):1539-1543. PubMed ID: 27592160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.
    Harpe SE; Inocencio TJ; Pakyz AL; Oinonen MJ; Polk RE
    Pharmacotherapy; 2012 Aug; 32(8):744-54. PubMed ID: 23307522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burden of Clostridium (Clostridioides) difficile infection during inpatient stays in the USA between 2012 and 2016.
    Mollard S; Lurienne L; Heimann SM; Bandinelli PA
    J Hosp Infect; 2019 Jun; 102(2):135-140. PubMed ID: 30690052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The burden of Clostridium difficile in surgical patients in the United States.
    Zerey M; Paton BL; Lincourt AE; Gersin KS; Kercher KW; Heniford BT
    Surg Infect (Larchmt); 2007 Dec; 8(6):557-66. PubMed ID: 18171114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis.
    Lawes T; Lopez-Lozano JM; Nebot CA; Macartney G; Subbarao-Sharma R; Wares KD; Sinclair C; Gould IM
    Lancet Infect Dis; 2017 Feb; 17(2):194-206. PubMed ID: 27825595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a Clostridium difficile infection management policy with clinical pharmacy and medical microbiology involvement at a major Canadian teaching hospital.
    Yeung SS; Yeung JK; Lau TT; Forrester LA; Steiner TS; Bowie WR; Bryce EA
    J Clin Pharm Ther; 2015 Dec; 40(6):655-60. PubMed ID: 26547905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication risk factors associated with healthcare-associated Clostridium difficile infection: a multilevel model case-control study among 64 US academic medical centres.
    Pakyz AL; Jawahar R; Wang Q; Harpe SE
    J Antimicrob Chemother; 2014 Apr; 69(4):1127-31. PubMed ID: 24327619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings.
    Aldeyab MA; Kearney MP; Scott MG; Aldiab MA; Alahmadi YM; Darwish Elhajji FW; Magee FA; McElnay JC
    J Antimicrob Chemother; 2012 Dec; 67(12):2988-96. PubMed ID: 22899806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Comprehensive Study of Costs Associated With Recurrent Clostridium difficile Infection.
    Rodrigues R; Barber GE; Ananthakrishnan AN
    Infect Control Hosp Epidemiol; 2017 Feb; 38(2):196-202. PubMed ID: 27817758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital Clostridium difficile Infection Rates and Prediction of Length of Stay in Patients Without C. difficile Infection.
    Miller AC; Polgreen LA; Cavanaugh JE; Polgreen PM
    Infect Control Hosp Epidemiol; 2016 Apr; 37(4):404-10. PubMed ID: 26858126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of community-acquired Clostridium difficile infection: the experience of a French hospital and review of the literature.
    Ogielska M; Lanotte P; Le Brun C; Valentin AS; Garot D; Tellier AC; Halimi JM; Colombat P; Guilleminault L; Lioger B; Vegas H; De Toffol B; Constans T; Bernard L
    Int J Infect Dis; 2015 Aug; 37():36-41. PubMed ID: 26092300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do antimicrobial stewardship programme interventions reduce the rate of and protect against Clostridium difficile infection?
    Chia BY; Teo JQ; Lee W; Liew YX; Ee RP; Chlebicki MP; Oon LL; Kwa AL
    J Glob Antimicrob Resist; 2019 Jun; 17():312-315. PubMed ID: 30682564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the Effectiveness of an Antimicrobial Stewardship Program on Reducing the Incidence Rate of Healthcare-Associated Clostridium difficile Infection: A Non-Randomized, Stepped Wedge, Single-Site, Observational Study.
    DiDiodato G; McArthur L
    PLoS One; 2016; 11(6):e0157671. PubMed ID: 27309536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High morbidity and mortality of Clostridium difficile infection and its associations with ribotype 002 in Hong Kong.
    Wong SH; Ip M; Hawkey PM; Lo N; Hardy K; Manzoor S; Hui WW; Choi KW; Wong RY; Yung IM; Cheung CS; Lam KL; Kwong T; Wu WK; Ng SC; Wu JC; Sung JJ; Lee N
    J Infect; 2016 Aug; 73(2):115-22. PubMed ID: 27246801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of an antimicrobial stewardship bundle for patients with Clostridium difficile infection.
    Brumley PE; Malani AN; Kabara JJ; Pisani J; Collins CD
    J Antimicrob Chemother; 2016 Mar; 71(3):836-40. PubMed ID: 26661392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.